Suppr超能文献

50 岁及以上男男性行为者中无论是否伴有 HIV,肛门人乳头瘤病毒感染和肛门高级别鳞状上皮内病变的流行率。

Prevalence of Anal Human Papillomavirus Infection and Anal High-Grade Squamous Intraepithelial Lesions Among Men Who Have Sex With Men 50 Years and Older Living With or Without HIV.

机构信息

Department of Medicine, University of California, San Francisco, CA.

Public Health Program, College of Education and Health Sciences, Touro University, Vallejo, CA.

出版信息

J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):439-446. doi: 10.1097/QAI.0000000000003450.

Abstract

BACKGROUND

Anal cancer is caused by human papillomavirus (HPV), particularly HPV-16, and is preceded by anal high-grade squamous intraepithelial lesions (HSILs). The incidence of anal cancer is highest among men who have sex with men (MSM) living with HIV (MSMLWH) and increases with age. However, most previous studies of anal HPV infection and anal HSIL were performed on men under 50 years old, and relatively little is known about HSIL among older MSMLWH or MSM not living with HIV (MSM-Not-LWH).

SETTING

We enrolled MSM who were aged 50+ during 2018-2022 in San Francisco, CA.

METHODS

One hundred twenty-nine MSMLWH and 109 MSM-not-LWH participated. All participants had anal HPV DNA testing (Atila Biosystems) and high-resolution anoscopy with a biopsy of visible lesions.

RESULTS

Among MSMLWH, 47% had anal HSIL, 19% had HPV-16, and 51% had other oncogenic anal HPV types (excluding HPV-16). Among MSM-not-LWH, 37% had anal HSIL, 22% had HPV-16, and 34% had other oncogenic anal HPV types. Increasing age was not statistically associated with prevalent HSIL, HPV-16, or other oncogenic HPV infections in MSMLWH or MSM-not-LWH. HPV-16 (odds ratio: 45.1, 95% confidence interval: 15.8-129); other oncogenic HPV types (odds ratio: 5.95, 95% confidence interval: 2.74-12.9) were associated with increased odds of anal HSIL, adjusted for age, income, education, and HIV status.

CONCLUSION

The prevalence of oncogenic anal HPV, anal HPV-16, and anal HSIL remains very high in older MSMLWH and MSM-not-LWH. With recent evidence showing that treating anal HSIL prevents anal cancer, MSM aged 50+ should be considered for anal cancer screening.

摘要

背景

肛门癌由人乳头瘤病毒(HPV)引起,尤其是 HPV-16,并且发生在肛门高级别鳞状上皮内病变(HSIL)之前。肛门癌的发病率在感染 HIV 的男男性行为者(MSMLWH)中最高,并且随年龄增长而增加。然而,大多数关于肛门 HPV 感染和肛门 HSIL 的先前研究都是针对 50 岁以下的男性进行的,对于年龄较大的 MSMLWH 或未感染 HIV 的男男性行为者(MSM-Not-LWH)中的 HSIL 知之甚少。

地点

我们于 2018-2022 年在加利福尼亚州旧金山招募了年龄在 50 岁以上的男男性行为者。

方法

129 名 MSMLWH 和 109 名 MSM-Not-LWH 参与了研究。所有参与者均接受了肛门 HPV DNA 检测(Atila Biosystems)和高分辨率肛门镜检查,并对可见病变进行活检。

结果

在 MSMLWH 中,47%患有肛门 HSIL,19%感染 HPV-16,51%感染其他致癌性肛门 HPV 型(不包括 HPV-16)。在 MSM-Not-LWH 中,37%患有肛门 HSIL,22%感染 HPV-16,34%感染其他致癌性肛门 HPV 型。在 MSMLWH 或 MSM-Not-LWH 中,年龄的增长与普遍存在的 HSIL、HPV-16 或其他致癌性 HPV 感染无统计学关联。HPV-16(优势比:45.1,95%置信区间:15.8-129);其他致癌性 HPV 型(优势比:5.95,95%置信区间:2.74-12.9)与肛门 HSIL 的发生风险增加相关,调整了年龄、收入、教育和 HIV 状况。

结论

在年龄较大的 MSMLWH 和 MSM-Not-LWH 中,致癌性肛门 HPV、肛门 HPV-16 和肛门 HSIL 的患病率仍然非常高。最近的证据表明,治疗肛门 HSIL 可预防肛门癌,因此应考虑对 50 岁以上的男男性行为者进行肛门癌筛查。

相似文献

5
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Natural History of Anal Squamous Intraepithelial Lesions in HIV-Positive Men with Normal Baseline Cytology.
AIDS Patient Care STDS. 2019 Nov;33(11):459-465. doi: 10.1089/apc.2019.0186.
10
Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV.
Int J Cancer. 2024 Jan 1;154(1):21-27. doi: 10.1002/ijc.34734. Epub 2023 Sep 20.

本文引用的文献

4
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
N Engl J Med. 2022 Jun 16;386(24):2273-2282. doi: 10.1056/NEJMoa2201048.
6
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Screening for Cervical Cancer.
Med Clin North Am. 2020 Nov;104(6):1063-1078. doi: 10.1016/j.mcna.2020.08.006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验